tiprankstipranks
Trending News
More News >
Incyte Corp (INCY)
NASDAQ:INCY
Advertisement

Incyte (INCY) Similar Stocks

Compare
1,739 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Incyte
$68.94
$13.40B
213.30
3.02%
7 Buy
9 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$58.37
$10.86B
21.67
-29.96%
16 Buy
5 Hold
0 Sell
Strong Buy
Exelixis
$44.87
$12.22B
20.36
98.89%
10 Buy
8 Hold
0 Sell
Moderate Buy
United Therapeutics
$297.33
$13.23B
11.90
-9.67%
9 Buy
3 Hold
0 Sell
Strong Buy
Ascendis Pharma
$177.20
$10.55B
31.06%
15 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$22.01
$13.48B
12.36
-19.20%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
67.86
1.99
3.02%
BMRN
BioMarin Pharmaceutical
58.37
-25.72
-30.59%
EXEL
Exelixis
44.87
22.27
98.54%
UTHR
United Therapeutics
297.33
-31.83
-9.67%
ASND
Ascendis Pharma
177.20
41.99
31.06%
GMAB
Genmab
22.01
-5.74
-20.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis